Akebia Therapeutics
AKBA
#6789
Rank
โ‚น42.75 B
Marketcap
โ‚น163.68
Share price
-1.04%
Change (1 day)
7.25%
Change (1 year)

Revenue for Akebia Therapeutics (AKBA)

Revenue in 2024 (TTM): โ‚น13.47 Billion

According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น13.72 Billion. a decrease over the revenue in the year 2023 that were of โ‚น16.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Akebia Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น13.74 B-15.19%
2023 โ‚น16.20 B-32.94%
2022 โ‚น24.15 B51.98%
2021 โ‚น15.89 B-26.39%
2020 โ‚น21.59 B-9.6%
2019 โ‚น23.88 B64.46%
2018 โ‚น14.52 B27.82%
2017 โ‚น11.36 B10794.79%
2016 โ‚น0.10 B
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.864 T 20,766.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.432 T 32,189.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น7.611 T 55,350.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.98 B-41.85%๐Ÿ‡บ๐Ÿ‡ธ USA